Peter Attia MD343–The evolving role of radiation: cancer treatment, low-dose treatments for arthritis, & much more
CHAPTERS
- 0:00 – 5:53
Radiation oncology as a young field and what this episode will cover
Peter Attia welcomes radiation oncologist Sanjay Mehta, also founder of MD Motorheads, and explains why he wanted the conversation: radiation oncology is a black box to many, and low-dose radiation for injuries is intriguing. Mehta describes the specialty as one of the youngest in medicine, becoming its own discipline in the 1970s–80s.
- •Mehta is a radiation oncologist and founder of the MD Motorheads Facebook group of doctors
- •Attia wanted to cover cancer treatment and low-dose radiation for nagging orthopedic injuries
- •Before the 1970s radiology fellows trained briefly on Cobalt-60 machines and did crude treatments
- •Radiation oncology residency is now an intern year plus four years, separate from diagnostics
- 5:53 – 8:46
What radiation is: the spectrum and ionizing vs non-ionizing
Mehta explains radiation as part of the electromagnetic spectrum and the difference between non-ionizing and ionizing energy. He argues that radio waves, microwaves, and visible light cannot damage DNA, so cellphone fears are fallacies, whereas X-rays can.
- •Radiation spans radio waves to X-rays, with visible light a narrow band in the middle
- •Non-ionizing radiation can excite molecules but cannot eject an electron
- •Cellphone and microwave-oven fears are called fallacies
- •Therapeutic linear accelerators use megavoltage X-rays versus lower-energy diagnostic kilovoltage
- 8:46 – 14:28
Measuring dose: grays, sieverts, and real-world exposures
The two discuss how radiation dose is measured and how grays relate to sieverts. They anchor the numbers with background exposure, altitude, pilots, the NRC limit, and the low exposure of radiation staff behind shielding.
- •A gray is absorbed dose in tissue and a sievert is exposure; for practical purposes they are equivalent, and 100 rads equal one gray
- •Sea-level living gives 1–2 millisieverts a year, roughly double that at altitude
- •The NRC recommends no more than 50 millisieverts a year
- •Staff are shielded and badged; older brachytherapy work produced some skin injuries
- 14:28 – 25:05
Low-dose exposure, LNT, hormesis, and everyday imaging
Mehta covers the whole-body versus tumor dose, chest X-ray doses, and the ALARA principle. He criticizes the linear no-threshold model, raises possible hormesis at low doses, and says that dental X-rays, mammograms, CTs, and PET/CTs are worth their risk-benefit.
- •Chest X-rays and mammograms are around or below one millisievert
- •LNT extrapolates from high-dose data and Mehta calls it erroneous at very low doses
- •Animal studies hint at hormesis, which he says is controversial
- •Mehta would prioritize image quality over small dose differences for CT angiograms
- •Dental X-rays, mammograms, and PET/CT are worth the dose
- 25:05 – 35:20
Breast cancer radiation: from mastectomy to lumpectomy and planning
Pivoting to therapy, they note breast and prostate are the most common radiation oncology cancers. Mehta explains the shift from radical mastectomy to lumpectomy with radiation, then walks through timing, simulation, positioning, and tangential beams.
- •Randomized data in the 1980s showed lumpectomy plus radiation matched mastectomy for survival
- •Typical treatment is about 40 gray in 15 fractions, with a boost to the tumor bed
- •Simulation uses a molded vacuum bag, CT planning, and 3D modeling
- •Whole-breast treatment is standard, with partial breast for selected small tumors
- •Axillary nodes are treated depending on risk factors
- 35:20 – 42:46
How treatment delivery has been automated and made precise
Mehta describes daily treatments of about 15 minutes that patients barely feel, and how his residency spanned the shift from lead blocks to CT planning. He explains linear accelerators, multi-leaf collimators, and daily image guidance.
- •Patients feel nothing and often go straight back to work or the gym
- •Hand-drawn fields and lead blocks gave way to virtual planning and automated beam shaping
- •Daily imaging overlays and a motorized table correct setup by millimeters
- •Linear accelerators produce X-rays by hitting a tungsten target with electrons, replacing Cobalt-60
- 42:46 – 48:01
Dose, homogeneity, and side effects: then versus now in breast treatment
Mehta explains that dose per fraction matters, so 40 gray in 15 fractions is biologically equivalent to the old 50 gray. The older cobalt-era plans had hot and cold spots that caused severe dermatitis and sometimes geographic recurrence, while modern skin reactions are mild.
- •Biologically equivalent dose matters more than total dose
- •Hot and cold spots in older plans caused scarring or geographic misses
- •Modern skin reaction is usually grade one or two redness
- •Very large-breasted patients may still receive 50 gray in 25 fractions
- •Nausea and vomiting are not seen with breast treatment
- 48:01 – 51:46
Breast implants and tissue expanders during radiation
Attia asks how implants affect treatment. Mehta says photons are essentially unaffected by silicone or saline, while tissue expanders in post-mastectomy reconstruction require careful beam modulation and coordination among the surgical teams.
- •Implants are tissue-equivalent to the beam and generally tolerate radiation
- •Capsular contracture from fibrosis is a possible later issue
- •Expanders require avoiding hot spots that could force removal or revision
- •Metal in some expanders can be modeled by modern planning systems
- 51:46 – 1:02:43
Prostate radiation: patient selection, androgen deprivation, and quality of life
Attia asks which prostate patients get radiation, and Mehta explains that radiation is now an option for nearly anyone eligible for surgery, with cure rates essentially equivalent. They discuss Gleason-based use of androgen deprivation, Decipher and Artera tests, quality-of-life advantages, and techniques to spare the rectum and bladder.
- •Radiation was once limited to medically inoperable patients, which skewed older data
- •Androgen deprivation is standard for high-risk disease, but Decipher and Artera can spare some intermediate-risk patients
- •Patients choose radiation to avoid incontinence and impotence
- •A full bladder and empty bowel help separate organs from the prostate
- •Patient motion is handled by margins and the ability to pause the beam
- 1:02:43 – 1:11:42
Gleason 6 observation, PSMA PET, and metastatic prostate cases
They discuss why some Gleason 6 patients choose radiation over observation and why no randomized trial exists. Mehta also explains how PSMA PET lets him treat isolated recurrences, the role of radiation for bone mets, and a patient with a PSA of 1900 who is still alive 12 years later.
- •No trial compares Gleason 6 watchful waiting with radiation; only observational data exist
- •Roughly a quarter of Gleason 7 patients may avoid androgen deprivation with low Decipher or Artera scores
- •PSMA PET allows targeted treatment of recurrent nodes instead of years of ADT
- •SBRT can treat spine or bone mets and oligometastatic disease
- •A patient with a PSA of 1900 did very well after systemic therapy and prostate radiation
- 1:11:42 – 1:14:44
Choosing a radiation oncologist
Attia asks what patients should ask when engaging a radiation oncologist. Mehta says hard metrics are scarce, so patients should look for experience in their cancer site, ask about complications, and use the consultation to judge the doctor.
- •Outcome metrics are hard to find, and top specialists often handle harder cases
- •Look for a doctor who specializes in the tumor site
- •Engineers or informed patients can ask to see dose volume histograms
- •Mehta spends an hour overpreparing patients about side effects
- 1:14:44 – 1:25:28
Brain radiation: whole brain, radiosurgery, GBM, and protons
Attia asks about radiation for brain tumors. Mehta explains the move from whole-brain radiation to focused radiosurgery because of cognitive side effects, hippocampal sparing with IMRT, the grim outlook for glioblastoma, proton therapy, prophylactic cranial radiation for small cell lung cancer, and gamma knife.
- •Whole-brain radiation of 30 gray in 10 fractions caused late cognitive problems
- •IMRT can carve dose away from the hippocampus
- •Glioblastoma gets about 60 gray, with survival measured in months to a couple of years
- •Protons stop at a depth and may reduce integral dose, especially in children
- •Prophylactic cranial radiation for small cell lung cancer sharply cuts CNS failures
- 1:25:28 – 1:31:48
Origins of radiophobia and the surprising history of radiation exposure
Attia uses radiophobia as a bridge to benign uses of radiation. Mehta traces US radiophobia to the Cold War, an oil-industry lobby, World War II, and the radium dial painters, while arguing that many historical exposures produced fewer problems than expected.
- •Radiophobia is largely a US phenomenon, while Europe kept using radiation for benign conditions
- •Mehta cites the Cold War, Standard Oil lobbying, Hiroshima, and the Radium Girls as drivers
- •Only a small fraction of radium dial painters had toxic effects
- •Radium nasal treatments in children had few reported adverse outcomes
- •Mehta argues human DNA is more resilient than commonly believed
- 1:31:48 – 1:38:57
Low-dose radiation for tendonitis and arthritis
Attia recounts how his Achilles tendonitis led to this topic, and Mehta explains the German-style protocol of half a gray six times over two weeks. He describes success rates, plantar fasciitis results, his own Achilles treatment, and early use for hamstring tendinopathy.
- •The protocol is 0.5 gray three times a week for two weeks, about the dose of one cancer fraction in total
- •Success rates are about 60–80%, rising above 90% with retreatment after 12 weeks
- •Plantar fasciitis often improves within a week, while Achilles took about two months
- •Mehta treated his own Achilles and compared it with steroids and PRP on the other side
- •Low doses work as an anti-inflammatory effect like cortisone, but are more durable
- 1:38:57 – 1:45:11
Spine, fibrosis, Dupuytren's, and keloids
They discuss spinal conditions, where data are weaker, and why large fields are used for inflammatory conditions. Mehta then covers higher-dose treatments for Dupuytren's contracture, Ledderhose disease, and keloids, including same-day radiation after resection.
- •Spinal osteoarthritis and SI joints show some benefit, but roughly half the extremity success rate
- •Larger fields are better for low-dose inflammatory treatment
- •Dupuytren's and Ledderhose need about 3 gray times five, repeated after a few weeks
- •Keloids need radiation the same day as surgical resection
- •Many people suffer needlessly with chronic injuries
- 1:45:11 – 1:55:16
Barriers to adoption, insurance, durability, and other uses
They discuss why low-dose radiation is underused: linear accelerator capacity, skepticism from surgeons, and radiophobia. Mehta notes Medicare and private coverage, limited randomized data, expected durability of months to years, and uses for rheumatoid arthritis and tennis elbow.
- •Orthovoltage machines could expand access without heavy shielding
- •Surgeons are mostly negative, though radiation does not preclude later surgery
- •Medicare and private insurers have covered it, with peer-to-peer reviews
- •Randomized data are limited and may never come
- •Benefit may last months to years, and rheumatoid arthritis can be helped locally for pain
- 1:55:16 – 1:59:26
Drumming, music, and the road to cars
The conversation turns to Mehta's drumming, his doctor cover band, and his favorite drummers. They then recall how they met at a drifting school.
- •Mehta plays with doctor friends and once fronted a band called Ultrasound
- •He names Neil Peart first among rock drummers and discusses jazz and math metal
- •Attia and Mehta met at an AMG drift academy
- 1:59:26 – 2:25:05
Dream cars, hypercars, and track stories
They discuss childhood car posters, dream garages, collector values, and the Holy Trinity of hypercars. Mehta shares track experiences with a Tesla Plaid's boiled brakes, the Taycan and Lucid, and the McLaren Senna, before a short wrap-up.
- •Mehta's grail cars include the McLaren F1, the first-generation Ford GT, and the Carrera GT
- •Collector car prices for Carrera GTs and F40s have roughly doubled in recent years
- •His stock Plaid boiled its brake fluid on the first hard stop at COTA and later got a Wilwood brake setup
- •Electric cars now outpace many supercars in acceleration, but heat is the limit on track
- •Both thank each other and close the episode
